10.1111/bjh.70100
Journal article
2025-12-01T00:00:00+00:00
207
2296 - 2313
17
BCL‐2 inhibitor, Bruton tyrosine kinase inhibitor, CD20 antibodies, CLL treatment, chemoimmunotherapy, vaccinations